Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Apr 13;12(1):109-115.
doi: 10.1159/000479220. eCollection 2018 Jan-Apr.

Cronkhite-Canada Syndrome Associated with Metastatic Colon Cancer

Affiliations
Case Reports

Cronkhite-Canada Syndrome Associated with Metastatic Colon Cancer

Shirin Haghighi et al. Case Rep Gastroenterol. .

Abstract

Cronkhite-Canada syndrome is characterized by gastrointestinal and ectodermal manifestations. In this paper, we describe a 64-year-old Iranian male, presenting with Cronkhite-Canada syndrome with metastatic colon cancer. The patient was suffering from hair loss, which occurred on the scalp at first and then, during 5 months, extended to the whole body. After that, his sense of taste was impaired, and 2 months later, gastrointestinal symptoms gradually started, with weight loss of 20 kg over 2 months with an initial weight of 100 kg. Finally, he was admitted to our center 10 months after the onset of symptoms. On skin examination, generalized hair loss and hyperpigmentation and dysmorphic nail changes were observed. Multiple polyps within the colon and sigmoid were observed on colonoscopy. According to biopsies, a serrated adenoma and an invasive adenocarcinoma were reported in the ascending colon and sigmoid, respectively. Other polyps were pseudopolyps, and their characteristics were not significant. Computed tomography of the lungs and abdomen showed multiple adenopathies. On biopsy, metastatic adenocarcinoma was reported. The patient underwent chemotherapy with FOLFIRI and ERBITUX. Finally, after 5 courses of chemotherapy, his regimen was changed to FOLFOX and Avastin because of evidence of progression on computed tomography. The etiology of Cronkhite-Canada syndrome is currently unknown, and the optimal therapy has not been reported so far. This syndrome has many complications; the major of them is malignancy, and the prognosis is poor with a mortality rate of 50%. Therefore, annual monitoring is necessary in these patients.

Keywords: Colorectal cancer; Cronkhite-Canada syndrome; Generalized hair loss; Polyposis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Hair loss.
Fig. 2.
Fig. 2.
Dysmorphic changes of nails.

Similar articles

Cited by

References

    1. Samoha S, Arber N. Cronkhite-Canada syndrome. Digestion. 2005;71:199–200. - PubMed
    1. Rubio CA, Björk J. Cronkhite-Canada syndrome – a case report. Anticancer Res. 2016;36:4215–4217. - PubMed
    1. Kao KT, Patel JK, Pampati V. Cronkhite-Canada syndrome: a case report and review of literature. Gastroenterol Res Pract. 2009;2009:619378. - PMC - PubMed
    1. Samet JD, Horton KM, Fishman EK, Iacobuzio-Donahue CA. Cronkhite-Canada syndrome: gastric involvement diagnosed by MDCT. Case Rep Med. 2009;2009:148795. - PMC - PubMed
    1. Kopáčová M, Urban O, Cyrany J, Laco J, Bureš J, Rejchrt S, Bártová J, Tachecí I. Cronkhite-Canada syndrome: review of the literature. Gastroenterol Res Pract. 2013;2013:856873. - PMC - PubMed

Publication types

LinkOut - more resources